DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,651,059 | -6.3% | 103,390 | -9.3% | 0.08% | +1.3% |
| Q2 2023 | $27,362,640 | -2.5% | 114,011 | +2.4% | 0.08% | -8.1% |
| Q1 2023 | $28,051,296 | +7.7% | 111,297 | +13.4% | 0.09% | -5.5% |
| Q4 2022 | $26,040,091 | +2.5% | 98,109 | -0.3% | 0.09% | -7.1% |
| Q3 2022 | $25,411,000 | -6.9% | 98,381 | -8.6% | 0.10% | +7.7% |
| Q2 2022 | $27,302,000 | -35.7% | 107,689 | -25.6% | 0.09% | 0.0% |
| Q1 2022 | $42,430,000 | -13.0% | 144,648 | -2.4% | 0.09% | -5.2% |
| Q4 2021 | $48,766,000 | +36.5% | 148,222 | +26.3% | 0.10% | -4.0% |
| Q3 2021 | $35,739,000 | +9.9% | 117,393 | -3.2% | 0.10% | +5.3% |
| Q2 2021 | $32,533,000 | +40.7% | 121,229 | +18.0% | 0.10% | +30.1% |
| Q1 2021 | $23,116,000 | +5.8% | 102,703 | +4.4% | 0.07% | -9.9% |
| Q4 2020 | $21,847,000 | +28.7% | 98,348 | +24.8% | 0.08% | +3.8% |
| Q3 2020 | $16,975,000 | +25.9% | 78,833 | +3.4% | 0.08% | +8.3% |
| Q2 2020 | $13,488,000 | +46.8% | 76,276 | +14.9% | 0.07% | +9.1% |
| Q1 2020 | $9,189,000 | -46.7% | 66,393 | -40.9% | 0.07% | -17.5% |
| Q4 2019 | $17,235,000 | +33.9% | 112,292 | +26.0% | 0.08% | +11.1% |
| Q3 2019 | $12,875,000 | +9.1% | 89,145 | +8.0% | 0.07% | +1.4% |
| Q2 2019 | $11,801,000 | -8.9% | 82,569 | -15.9% | 0.07% | -9.0% |
| Q1 2019 | $12,961,000 | +0.8% | 98,178 | -21.3% | 0.08% | -13.3% |
| Q4 2018 | $12,860,000 | -2.2% | 124,710 | +3.1% | 0.09% | +1.1% |
| Q3 2018 | $13,144,000 | +25.7% | 120,967 | +14.1% | 0.09% | +27.1% |
| Q2 2018 | $10,458,000 | -4.7% | 105,982 | -5.5% | 0.07% | -2.8% |
| Q1 2018 | $10,979,000 | +8.6% | 112,130 | +3.0% | 0.07% | +2.9% |
| Q4 2017 | $10,105,000 | +42.9% | 108,865 | +32.1% | 0.07% | +7.7% |
| Q3 2017 | $7,070,000 | -5.1% | 82,417 | -6.6% | 0.06% | -12.2% |
| Q2 2017 | $7,451,000 | -1.7% | 88,287 | -0.4% | 0.07% | -6.3% |
| Q1 2017 | $7,580,000 | +12.5% | 88,623 | +2.4% | 0.08% | +5.3% |
| Q4 2016 | $6,737,000 | +76.7% | 86,547 | +78.0% | 0.08% | +41.5% |
| Q3 2016 | $3,812,000 | -32.3% | 48,626 | -12.7% | 0.05% | -26.4% |
| Q2 2016 | $5,627,000 | -2.8% | 55,713 | -8.8% | 0.07% | -10.0% |
| Q1 2016 | $5,792,000 | -27.9% | 61,058 | -29.4% | 0.08% | -17.5% |
| Q4 2015 | $8,031,000 | +17.2% | 86,468 | +7.5% | 0.10% | +1.0% |
| Q3 2015 | $6,853,000 | +14.7% | 80,426 | +15.2% | 0.10% | +15.7% |
| Q2 2015 | $5,976,000 | -21.3% | 69,819 | -21.9% | 0.08% | -6.7% |
| Q1 2015 | $7,591,000 | -10.0% | 89,412 | -9.2% | 0.09% | -9.2% |
| Q4 2014 | $8,439,000 | +23.2% | 98,461 | +9.2% | 0.10% | +7.7% |
| Q3 2014 | $6,849,000 | -10.3% | 90,148 | -7.0% | 0.09% | -8.1% |
| Q2 2014 | $7,632,000 | -4.6% | 96,944 | -9.1% | 0.10% | -1.0% |
| Q1 2014 | $8,002,000 | +3.8% | 106,698 | +6.9% | 0.10% | -13.0% |
| Q4 2013 | $7,708,000 | +140.7% | 99,845 | +116.1% | 0.12% | +51.3% |
| Q3 2013 | $3,202,000 | -41.2% | 46,193 | -46.3% | 0.08% | -29.0% |
| Q2 2013 | $5,445,000 | – | 86,024 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |